- Home
- IGIC vs TRML Comparison
IGIC vs TRML Comparison
Compare IGIC & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGIC
- TRML
- Stock Information
- Founded
- IGIC 2001
- TRML 2021
- Country
- IGIC Jordan
- TRML United States
- Employees
- IGIC N/A
- TRML N/A
- Industry
- IGIC Property-Casualty Insurers
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- IGIC Finance
- TRML Health Care
- Exchange
- IGIC Nasdaq
- TRML Nasdaq
- Market Cap
- IGIC 1.0B
- TRML 1.2B
- IPO Year
- IGIC N/A
- TRML N/A
- Fundamental
- Price
- IGIC $23.45
- TRML $47.90
- Analyst Decision
- IGIC Buy
- TRML Hold
- Analyst Count
- IGIC 2
- TRML 12
- Target Price
- IGIC $31.50
- TRML $47.04
- AVG Volume (30 Days)
- IGIC 86.6K
- TRML 2.1M
- Earning Date
- IGIC 11-04-2025
- TRML 11-06-2025
- Dividend Yield
- IGIC 0.85%
- TRML N/A
- EPS Growth
- IGIC 11.00
- TRML N/A
- EPS
- IGIC 2.79
- TRML N/A
- Revenue
- IGIC $535,109,000.00
- TRML N/A
- Revenue This Year
- IGIC $6.05
- TRML N/A
- Revenue Next Year
- IGIC $7.01
- TRML N/A
- P/E Ratio
- IGIC $8.40
- TRML N/A
- Revenue Growth
- IGIC 9.99
- TRML N/A
- 52 Week Low
- IGIC $18.45
- TRML $11.56
- 52 Week High
- IGIC $27.76
- TRML $48.27
- Technical
- Relative Strength Index (RSI)
- IGIC 44.33
- TRML 91.15
- Support Level
- IGIC $22.91
- TRML $47.67
- Resistance Level
- IGIC $23.79
- TRML $47.94
- Average True Range (ATR)
- IGIC 0.58
- TRML 0.11
- MACD
- IGIC -0.04
- TRML -0.80
- Stochastic Oscillator
- IGIC 40.14
- TRML 39.34
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.